not just results.
Testing to help identify the underlying cause and risk for cancer progression
Liver disease is a growing concern for health care providers, with approximately 844 million people suffering from chronic liver disease worldwide. Mayo Clinic Laboratories offers the only comprehensive testing menu for liver disease developed by clinical experts that enables health care providers to determine the underlying cause and rule out other causes for the disease.
The full spectrum of testing
A Test in Focus
Nikola Baumann, Ph.D., gives an overview of the new NASH-FibroTest available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical action can be taken due to the results of this testing.